When was Motif neurotech founded?

Motif neurotech was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Where is Motif neurotech located?

Motif neurotech is headquartered in Houston, United States.

Who is the current CEO of Motif neurotech?

Jacob Robinson of Motif neurotech. They have also founded 1 company.

How many employees does Motif neurotech have?

As of Jul 31, 2026, the latest employee count at Motif neurotech is 31.

Is Motif neurotech a funded company?

Motif neurotech is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jan 24, 2024.

When was the latest funding round of Motif neurotech?

Motif neurotech's latest funding was a $***** Series A round on Jan 24, 2024, with participation from 11 investors.

Where does Motif neurotech rank among its competitors?

Motif neurotech ranks 2nd amongst 35 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Spark Biomedical, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of Motif neurotech?

Motif neurotech's top competitors include Freespira, NeuroSigma and Spark Biomedical. Among them, Spark Biomedical secured the most recent funding round in August, 2025.

Motif neurotech - 2026 Company Profile, Team, Funding & Competitors

Motif neurotech is a series A company based in Houston (United States), founded in 2022 by Jacob Robinson. It operates as a Developer of minimally invasive bioelectronics for mental health disorders. Motif neurotech has raised $18.8M in funding from Arboretum Ventures. The company has 35 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like Freespira, NeuroSigma and Spark Biomedical.

Company Details

Developer of minimally invasive bioelectronics for mental health disorders. It offers a miniature brain pacemaker that stimulate the brain to restore healthy circuit activity and treat mental health disorders like treatment resistant depression.

Website: motifneuro.tech
Email ID: *****@motifneuro.tech

Key Metrics

Founded Year

2022

Location

Houston, United States

Stage

Series A

Total Funding

$18.8M in 1 round

Latest Funding Round

Series A, Jan 24, 2024, $*****

Investors

Arboretum Ventures & 10 more

Ranked

2^nd among 35 active competitors

Employee Count

31 as on Jul 31, 2026

Similar Companies

Freespira & 47 more

View Motif neurotech's full profile

Motif neurotech has raised a total funding of $18.8M over 1 round. Its latest funding round was a Series A round on Jan 24, 2024 for $*****. 11 investors participated in its latest round. Motif neurotech has 10 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Motif neurotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 24, 2024	9981422	Series A	1133165	8007907	9244660	5181158

Access funding benchmarks and valuations. Sign up today!

View details of Motif neurotech's funding rounds and investors

The founders of Motif neurotech is Jacob Robinson. Jacob Robinson is the CEO of Motif neurotech.

Here are the details of Motif neurotech's key team members:

Jacob Robinson: Co-Founder & CEO of Motif neurotech.
Contact Info: 1 email address

View details of Motif neurotech's Founder profiles and Board Members

Motif neurotech's employee count trend

Motif neurotech has 31 employees as of Jul 26. Here is Motif neurotech's employee count trend over the years:

Employee count trend for Motif neurotech

Uncover Motif neurotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Motif neurotech include Freespira, NeuroSigma and Spark Biomedical. Here is the list of Top 10 competitors of Motif neurotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Lightspeed Venture Partners, Aphelion Capital ... & 4 others	60/100
2nd	Motif neurotech 2022, Houston (United States), Series A	Developer of minimally invasive bioelectronics for mental health disorders	$18.8M	re.Mind Capital, Dolby Family Ventures & 9 others	60/100
3rd	NeuroSigma 2008, Los Angeles (United States), Seed	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	59/100
4th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
5th	Cervel 2008, Redwood City (United States), Acquired	Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression	$23.6M	Aberdare Ventures, The D. E. Shaw Group & 1 others	49/100
6th	Nexalin 2010, Tustin (United States), Public	A non-invasive and drug free treatment for the treatment of anxiety, depression and insomnia	$502K	-	47/100
7th	Neuroelectrics 2011, Barcelona (Spain), Series A	Provider of wireless EEG monitoring and brain stimulation devices	$17.9M	Morningside, Intelectium & 3 others	43/100
8th	Rio Grande Neurosciences 2011, San Francisco (United States), Series A	Non-invasive brain stimulation therapies	$8.93M	-	41/100
9th	Thync 2011, Los Gatos (United States), Series B	Neuro-signaling headgear that changes state of mind	$13M	Andreessen Horowitz, Noosphere Ventures & 2 others	40/100
10th	Inner Cosmos 2017, Portola Valley (United States), Seed	Provider of AI-based device for treating mood and addiction disorders	$11.9M	Lool Ventures, Starlight Ventures & 5 others	39/100